[1]
|
Ryu, G.W., Park, Y.S., Kim, J., et al. (2022) Incidence and Prevalence of Peripheral Arterial Disease in South Korea: Retrospective Analysis of National Claims Data. JMIR Public Health and Surveillance, 8, e34908.
https://doi.org/10.2196/34908
|
[2]
|
Mandaglio-Collados, D., Marín, F. and Rivera-Caravaca, J.M. (2023) Peripher-al Artery Disease: Update on Etiology, Pathophysiology, Diagnosis and Treatment. Medicina Clinica, 161, 344-350.
https://doi.org/10.1016/j.medcli.2023.06.005
|
[3]
|
Bredikhin, R.A., Krepkogorskiĭ, N.V. and Khaĭrullin, R.N. (2021) Are There Alternatives to Dual Antiplatelet Therapy after Stenting of Peripheral Arteries? Angiology and Vascular Sur-gery, 27, 22-27.
https://doi.org/10.33529/ANGID2021313
|
[4]
|
Kokkinidis, D.G., Katsaros, I., Jonnalagadda, A.K., Avner, S.J. and Chaitidis, N. (2019) Use, Safety and Effectiveness of Subintimal Angioplasty and Re-Entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions: A Systematic Review of 87 Studies and 4,665 Patients. Cardiovascular Re-vascularization Medicine: Including Molecular Interventions, 21, 34-45. https://doi.org/10.1016/j.carrev.2019.03.016
|
[5]
|
Golledge, J., Golledge, J. and Golledge, J. (2022) Update on the Pathophysiology and Medical Treatment of Peripheral Artery Disease. Nature Reviews Cardiology, 19, 456-474. https://doi.org/10.1038/s41569-021-00663-9
|
[6]
|
Polonsky, T.S., McDermott, M.M. and McDermott, M.M. (2021) Lower Extremity Peripheral Artery Disease without Chronic Limb-Threatening Ischemia: A Review. JAMA, 325, 2188-2198. https://doi.org/10.1001/jama.2021.2126
|
[7]
|
Lin, S.G., Lin, R.R., Zhang, H.K., Xu, Q.B. and He, Y.Y. (2022) Peripheral Vascular Remodeling during Ischemia. Frontiers in Pharmacology, 13, Article ID: 1078047. https://doi.org/10.3389/fphar.2022.1078047
|
[8]
|
Horváth, L., Horváth, L., Németh, N., Fehér, G. and Fehér, G. (2022) Epidemiology of Peripheral Artery Disease: Narrative Review. Life (Basel, Switzerland), 12, Article No. 1041. https://doi.org/10.3390/life12071041
|
[9]
|
Chuter, V., Schaper, N., Mills, J., Hinchliffe, R. and Russell, D. (2023) Effectiveness of Revascularisation for the Ulcerated Foot in Patients with Diabetes and Peripheral Artery Disease: A Systematic Review. Diabetes/Metabolism Research and Reviews, e3700. https://doi.org/10.1002/dmrr.3700
|
[10]
|
Feldman, D.N., Armstrong, E.J., Aronow, H.D., Gigliotti, O.S. and Jaff, M.R. (2018) SCAI Consensus Guidelines for Device Selection in Femoral-Popliteal Arterial Interventions. Catheteriza-tion and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions, 92, 124-140. https://doi.org/10.1002/ccd.27635
|
[11]
|
Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M. and Kar-nabatidis, D. (2018) Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropoplit-eal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the Ameri-can Heart Association, 7, e011245.
https://doi.org/10.1161/JAHA.118.011245
|
[12]
|
Keefe, N., Shull, T., Botea, L. and McGinigle, K. (2023) Drug-Coated Balloon versus Drug-Eluting Stent: The Debate of Leave Nothing behind. Seminars in Interventional Radi-ology, 40, 161-166. https://doi.org/10.1055/s-0043-57261
|
[13]
|
Zeller, T., Brechtel, K., Meyer, D.-R., Noory, E. and Beschorner, U. (2020) Six-Month Outcomes from the First-in- Human, Single-Arm SELUTION Sus-tained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. Journal of Endovascular Therapy: An Of-ficial Journal of the International Society of Endovascular Specialists, 27, 683-690. https://doi.org/10.1177/1526602820941811
|
[14]
|
Amlani, V., Falkenberg, M. and Nordanstig, J. (2021) The Cur-rent Status of Drug-Coated Devices in Lower Extremity Peripheral Artery Disease Interventions. Progress in Cardio-vascular Diseases, 65, 23-28.
https://doi.org/10.1016/j.pcad.2021.02.002
|
[15]
|
Soga, Y., Fujihara, M., Yamamoto, Y., Nakamura, S. and Iida, O. (2021) One-Year Results for Japanese Patients in RANGER II SFA. Heart and Vessels, 37, 568-573. https://doi.org/10.1007/s00380-021-01947-3
|
[16]
|
Schroë, H., Sachar, R., Keirse, K., Soga, Y. and Brodmann, M. (2022) The RANGER II Superficial Femoral Artery Trial: 1-Year Results of the Long Lesion Cohort. Vascular Medicine (London, England), 27, 457-465.
https://doi.org/10.1177/1358863X221097164
|
[17]
|
Sachar, R., Soga, Y., Ansari, M.M., Kozuki, A. and Lopez, L. (2021) 1-Year Results from the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. JACC: Cardi-ovascular Interventions, 14, 1123-1133.
https://doi.org/10.1016/j.jcin.2021.03.021
|
[18]
|
Gray, W.A., Jaff, M.R., Parikh, S.A., Ansel, G.M. and Brodmann, M. (2019) Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years. Circulation, 140, 1145-1155. https://doi.org/10.1161/CIRCULATIONAHA.119.040518
|
[19]
|
Armstrong, A.J., Lin, P., Tombal, B., Saad, F. and Higano, C.S. (2020) Five-Year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemothera-py-Naïve Metastatic Castration-Resistant Prostate Cancer from the PREVAIL Trial. European Urology, 78, 347-357. https://doi.org/10.1016/j.eururo.2020.04.061
|
[20]
|
El Khoury, R., Brodmann, M. and Schneider, P.A. (2021) Pro-gress on Developing an Effective Below-the-Knee Drug- Coated Balloon. Reviews in Cardiovascular Medicine, 22, 585-595. https://doi.org/10.31083/j.rcm2203070
|
[21]
|
Shishehbor, M.H., Scheinert, D., Jain, A., Brodmann, M. and Tepe, G. (2022) Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients with Femoropopliteal Arteri-al Disease. Journal of the American College of Cardiology, 81, 237-249. https://doi.org/10.1016/j.jacc.2022.10.016
|
[22]
|
Sallustro, M., Peluso, A., Turchino, D., Maione, I. and Vita, F. (2022) Results of New Dual-Drug Coated Balloon Angioplasty versus POBA for Femoropopliteal Lesions. Annals of Vascular Surgery, 89, 52-59.
https://doi.org/10.1016/j.avsg.2022.09.047
|
[23]
|
Zhen, Y.H., Ren, H.Y., Chen, J., Chang, Z.H. and Wang, C.Z. (2021) Systematic Review and Meta-Analysis of Drug-Coated Balloon Angioplasty for In-Stent Restenosis in Fem-oropopliteal Artery Disease. Journal of Vascular and Interventional Radiology: JVIR, 33, 368-374.e6. https://doi.org/10.1016/j.jvir.2021.12.007
|
[24]
|
Haine, A., Schmid, M.J., Schindewolf, M., Lenz, A. and Bernhard, S.M. (2019) Comparison between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Fem-oropopliteal Artery Disease. European Journal of Vascular and Endovascular Surgery: The Official Journal of the Eu-ropean Society for Vascular Surgery, 58, 865-873.
https://doi.org/10.1016/j.ejvs.2019.09.002
|
[25]
|
Kuramitsu, S., Sonoda, S., Ando, K., Otake, H. and Natsuaki, M. (2021) Drug-Eluting Stent Thrombosis: Current and Future Perspectives. Cardiovascular Intervention and Therapeutics, 36, 158-168.
https://doi.org/10.1007/s12928-021-00754-x
|
[26]
|
Tsujimura, T., Takahara, M., Iida, O., Soga, Y. and Katsuki, T. (2021) Clinical Outcomes of Polymer-Free, Paclitaxel-Coated Stents vs Stent Grafts in Peripheral Arterial Disease Pa-tients with Femoropopliteal Artery Lesions. Journal of Vascular Surgery, 73, 1998-2008.E1. https://doi.org/10.1016/j.jvs.2020.12.061
|
[27]
|
Stavroulakis, K., Torsello, G., Bosiers, M., Argyriou, A. and Tsilimparis, N. (2021) 2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions. JACC: Cardiovascular Interventions, 14, 692-701. https://doi.org/10.1016/j.jcin.2021.01.026
|
[28]
|
Gouëffic, Y., Torsello, G., Zeller, T., Esposito, G. and Vermassen, F. (2022) Efficacy of a Drug-Eluting Stent versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial. Circulation, 146, 1564-1576.
|
[29]
|
Vanderland, M. and Gray, W.A. (2020) Zilver PTX Peripheral Paclitaxel-Eluting Stent: A Technology Evaluation. Expert Opinion on Drug Delivery, 17, 1335-1343. https://doi.org/10.1080/17425247.2020.1789586
|
[30]
|
Giannopoulos, S., Secemsky, E.A., Schneider, P.A. and Armstrong, E.J. (2022) Concomitant Drug-Coated Balloon Angioplasty with Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel? The Journal of Invasive Cardiology, 34, E469-E476.
|
[31]
|
Iida, O., Fujihara, M., Kawasaki, D., Mori, S. and Yokoi, H. (2021) 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent. Cardiovascular and Interventional Radiology, 44, 1367-1374. https://doi.org/10.1007/s00270-021-02901-6
|
[32]
|
Shibata, T., Iba, Y., Shingaki, M., Yamashita, O. and Tsu-bakimoto, Y. (2023) One Year Outcomes of Zilver PTX versus Eluvia for Femoropopliteal Disease in Real-World Prac-tice: REALDES Study. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovas-cular Specialists.
https://doi.org/10.1177/15266028231179861
|
[33]
|
Todd, M., Liu, L.B., Saul, J.M. and Yazdani, S.K. (2023) Pre-Clinical Investigation of Liquid Sirolimus for Local Drug Delivery. Frontiers in Cardiovascular Medicine, 10, Arti-cle ID: 1184816. https://doi.org/10.3389/fcvm.2023.1184816
|
[34]
|
Cawich, I., Armstrong, E.J., George, J.C., Gol-zar, J. and Shishehbor, M.H. (2022) Temsirolimus Adventitial Delivery to Improve ANGiographic Outcomes below the Knee. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists. https://doi.org/10.1177/15266028221131459
|
[35]
|
Razavi, M.K., Donohoe, D., D’Agostino, R.B., Jaff, M.R. and Adams, G. (2018) Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Super-ficial Femoral and Popliteal Artery Disease: 12-Month Results from the DANCE Clinical Trial. JACC: Cardiovascular Interventions, 11, 921-931.
https://doi.org/10.1016/j.jcin.2017.12.015
|
[36]
|
Geraghty, P.J., Adams, G.L., Schmidt, A., Lichtenberg, M. and Wissgott, C. (2020) Twelve-Month Results of Tack- Optimized Balloon Angioplasty Using the Tack Endovascular Sys-tem in Below-the-Knee Arteries (TOBA II BTK). Journal of Endovascular Therapy: An Official Journal of the Interna-tional Society of Endovascular Specialists, 27, 626-636. https://doi.org/10.1177/1526602820944402
|
[37]
|
Gray, W.A., Cardenas, J.A., Brodmann, M., Werner, M. and Bernardo, N.I. (2019) Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results from the TOBA II Study. JACC: Cardiovascular Interventions, 12, 2375-2384. https://doi.org/10.1016/j.jcin.2019.08.005
|
[38]
|
Vanderland, M., Ooi, Y.S. and Gray, W.A. (2021) Device Profile of the Tack Endovascular System® for the Treatment of Peripheral Arterial Disease: Overview of Safety and Efficacy. Expert Review of Medical Devices, 18, 717-726.
https://doi.org/10.1080/17434440.2021.1947243
|
[39]
|
Adams, G.L., Lichtenberg, M., Wissgott, C., Schmidt, A. and Tarra, T. (2022) Twenty-Four Month Results of Tack- Optimized Balloon Angioplasty Using the Tack Endovascular System in Below-the-Knee Arteries. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists, 30, 393-400.
https://doi.org/10.1177/15266028221083462
|
[40]
|
Brodmann, M., Werner, M., Sood, A. and Gray, W.A. (2023) Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: Tack Opti-mized Balloon Angioplasty II 24-Month Results. Vascular. https://doi.org/10.1177/17085381231162128
|
[41]
|
Brodmann, M., Wissgott, C., Brechtel, K., Lichtenberg, M. and Blessing, E. (2023) Optimized Drug-Coated Balloon Angioplasty of the Superficial Femoral and Proximal Popliteal Ar-teries Using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24-Month Results in Standard and Long Lesions. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardi-ac Angiography & Interventions, 102, 701-712.
https://doi.org/10.1002/ccd.30800
|
[42]
|
Thandra, A., Betts, L., Aggarwal, G., Gujjula, N. and Haddad, T.M. (2022) Intravascular Lithotripsy for Acute Stent Under-Expansion and In-Stent Restenosis: A Case Series. Current Problems in Cardiology, 48, Article ID: 101511.
https://doi.org/10.1016/j.cpcardiol.2022.101511
|
[43]
|
Benfor, B., Sinha, K., Lumsden, A.B. and Roy, T.L. (2023) Scoping Review of Atherectomy and Intravascular Lithotripsy with or without Balloon Angioplasty in Below-the-Knee Lesions. Journal of Vascular Surgery Cases and Innovative Techniques, 9, Article ID: 101185. https://doi.org/10.1016/j.jvscit.2023.101185
|
[44]
|
Giannopoulos, S. and Armstrong, E.J. (2022) Intravascular Lith-otripsy for Optimal Angioplasty of Infrapopliteal Calcified Lesions. The Journal of Invasive Cardiology, 34, E132-E141.
|
[45]
|
Vedani, S., Haligür, D., Jungi, S. and Bosiers, M.J. (2023) Intravascular Lithotripsy: A Powerful Tool to Treat Peripheral Artery Calcifications. The Journal of Cardiovascular Surgery, 64, 406-412.
https://doi.org/10.23736/S0021-9509.22.12535-8
|
[46]
|
Tepe, G., Brodmann, M., Werner, M., Bachinsky, W. and Holden, A. (2021) Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes from the Randomized Disrupt PAD III Trial. JACC: Cardiovascular Interventions, 14, 1352-1361. https://doi.org/10.1016/j.jcin.2021.04.010
|
[47]
|
Karimi, A., Lauria, A.L., Aryavand, B. and Neville, R.F. (2022) Novel Therapies for Critical Limb-Threatening Ischemia. Current Cardiology Reports, 24, 513-517. https://doi.org/10.1007/s11886-022-01669-6
|
[48]
|
Kereiakes, D.J., Virmani, R., Hokama, J.Y., Illindala, U. and Mena-Hurtado, C. (2021) Principles of Intravascular Lithotripsy for Calcific Plaque Modification. JACC: Cardiovascular Interventions, 14, 1275-1292.
https://doi.org/10.1016/j.jcin.2021.03.036
|
[49]
|
Halena, G., Krievins, D.K., Scheinert, D., Savlovskis, J. and Szopiński, P. (2021) Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System. Journal of Endo-vascular Therapy: An Official Journal of the International Society of Endovascular Specialists, 29, 84-95. https://doi.org/10.1177/15266028211034862
|
[50]
|
Krievins, D.K., Halena, G., Scheinert, D., Savlovskis, J. and Szopiński, P. (2020) One-Year Results from the DETOUR I Trial of the PQ Bypass DETOUR System for Percutaneous Femoropopliteal Bypass. Journal of Vascular Surgery, 72, 1648-1658.e2. https://doi.org/10.1016/j.jvs.2020.02.043
|
[51]
|
Rola, P., Rola, P., Włodarczak, S., Doroszko, A. and Lesiak, M. (2022) The Bioresorbable Magnesium Scaffold (Magmaris)-State of the Art: From Basic Concept to Clinical Application. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interven-tions, 100, 1051-1058.
https://doi.org/10.1002/ccd.30435
|
[52]
|
Toong, D.W.Y., Toh, H.W., Toh, H.W., Ng, J.C.K. and Ng, J.C.K. (2020) Bioresorbable Polymeric Scaffold in Cardiovascular Applications. International Journal of Molecular Sciences, 21, Arti-cle No. 3444.
https://doi.org/10.3390/ijms21103444
|
[53]
|
Wu, X.L., Wu, X.L., Wu, S.J., Wu, S.J. and Kawashima, H. (2021) Current Perspectives on Bioresorbable Scaffolds in Coronary Intervention and Other Fields. Expert Review of Medical Devices, 18, 1-15.
https://doi.org/10.1080/17434440.2021.1904894
|
[54]
|
Barkholt, T.Ø., Neghabat, O., Holck, E.N., Andreasen, L.N. and Christiansen, E.H. (2021) Bioresorbable Magnesium Scaffold in the Treatment of Simple Coronary Bifurcation Le-sions: The BIFSORB Pilot II Study. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions, 99, 1075-1083.
https://doi.org/10.1002/ccd.30051
|